WASHINGTON — In the RevElution study, a polymer-free drug-filled stent met the primary endpoint of in-stent late lumen loss at 9 months compared with a drug-eluting stent, and was also linked with ...
WASHINGTON - October 31, 2016 - A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late ...
REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback